NEOLA — Neola Medical AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK143.11m
- SEK121.53m
- 23
- 23
- 64
- 27
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.61 | -6.72 | -6.65 | -10.4 | -9.01 |
Depreciation | |||||
Non-Cash Items | 0.006 | 0.001 | 0.016 | 1.07 | 1.81 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.532 | 0.634 | -0.309 | 0.786 | 0.658 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.07 | -6.08 | -6.93 | -8.5 | -6.54 |
Capital Expenditures | -2.44 | -2.17 | -10.5 | -11.6 | -12.3 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Cash from Investing Activities | -2.44 | -2.17 | -10.5 | -11.6 | -12.3 |
Financing Cash Flow Items | — | -2.96 | — | — | -0.168 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 0 | 19.5 | 23.7 | 37.2 | 0.336 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -4.5 | 11.3 | 6.29 | 17.1 | -18.5 |